The FIRST and ONLY Dual Claim HIV-1 Assay

Aptima HIV-1 Quant Dx Assay

HCV has nowhere to hide

APTIMA HCV QUANT DX ASSAY

Dual-target HBV treatment management

APTIMA HBV QUANT ASSAY

See how Hologic is bringing its legacy of innovation to today’s world of molecular diagnostic testing.

Learn how real-time TMA leads to highly sensitive, highly specific assay performance.

The Power to Choose, The Potential to Grow

The Panther system has set the standard for flexibility, reliability and performance, serving as the foundation for assay consolidation, future scalability and growth.

Choose from a broad range of STI, Women’s health, Viral load and respiratory assays on a single, fully automated platform that best meets your laboratory needs today, while providing a scalable and economical path to expansion and growth for years to come.

Aptima® assays now available for:

  • CT/NG
  • Mycoplasma genitalium
  • Trichomonas vaginalis
  • Bacterial vaginosis
  • Candida vaginitis/Trichomonas vaginalis
  • HSV 1 & 2
  • HPV
  • HPV 16 18/45
  • SARS-CoV-2*
  • Zika Virus*
  • HIV-1 Quant Dx
  • HCV Quant Dx
  • HBV Quant
  • CMV†

CONTACT US

HOLOGIC

FOLLOW US

* The Aptima SARS-CoV-2, Aptima Zika Virus, Aptima SARS-CoV-2/Flu and Panther Fusion SARS-CoV-2 assays have not been FDA cleared or approved: These tests have been authorized by FDA under an EUA for use by authorized laboratories; The Aptima and Panther Fusion SARS-CoV-2 assays have been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens; The Aptima Zika Virus assay has been authorized only for the detection of nucleic acid from Zika virus, not for any other viruses or pathogens; The Aptima SARS-CoV-2/Flu assay has been authorized only for the simultaneous qualitative detection and differentiation of nucleic acid from SARS-CoV-2, influenza A virus, influenza B virus, and not for any other viruses or pathogens. The Aptima SARS-CoV-2, Panther Fusion SARS-CoV-2, and Aptima SARS-CoV-2/Flu assays are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner. The Aptima Zika assay is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection of Zika virus and/or diagnosis of Zika virus infection under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

 

† In development and not for sale.

 

‡ Follow local and state guidelines for waste disposal.

 

©2021 Hologic, Inc. All rights reserved. Hologic, Aptima, Panther, and associated logos are trademarks and/or registered trademarks of Hologic, Inc. and/or its subsidiaries in the United States and/or other countries. This information is intended for medical professionals in the U.S. and is not intended as a product solicitation or promotion where such activities are prohibited. Because Hologic materials are distributed through websites, eBroadcasts and tradeshows, it is not always possible to control where such materials appear. For specific information on what products are available for sale in a particular country, please contact your local Hologic representative or write to diagnostic.solutions@hologic.com

Enter your
text here